In summary, these data support our overall hypothesis that SMYD3 cooperates with the NuRD (MTA1/MTA2) complex to inhibit expression of a series of tumor suppressor genes, leading to tumor progression (Fig. 9e). The gene discussed is SMYD3; the disease is neoplasm.